Stay updated with breaking news from Nasdaq Aclx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arcellx (NASDAQ:ACLX – Free Report) had its target price trimmed by Stifel Nicolaus from $54.00 to $52.00 in a research note released on Tuesday morning, MarketBeat reports. The firm currently has a buy rating on the stock. ACLX has been the subject of several other research reports. Barclays increased their price target on shares of […]
Arcellx (NASDAQ:ACLX – Get Free Report) and X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 63.2% of X4 Pharmaceuticals […]
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totalling 7,630,000 shares, an increase of 16.7% from the June 15th total of 6,540,000 shares. Based on an average daily volume of 629,200 shares, the short-interest ratio is […]
Arcellx (NASDAQ:ACLX – Get Rating) had its target price cut by Truist Financial from $60.00 to $57.00 in a research report report published on Tuesday morning, The Fly reports. Other equities analysts also recently issued research reports about the company. Robert W. Baird cut their price objective on Arcellx from $55.00 to $40.00 in a […]
Arcellx (NASDAQ:ACLX – Get Rating) had its target price lowered by Robert W. Baird from $55.00 to $40.00 in a research report report published on Tuesday, The Fly reports. Several other equities research analysts have also recently issued reports on the company. SVB Leerink raised their price objective on Arcellx from $35.00 to $39.00 and […]